Lack of association between SLCO1B1 polymorphisms and lipid-lowering response to simvastatin therapy in Thai hypercholesterolaemic patients.

N KaewboonlertW ThitisopeeW SirintronsoponS PorntadavityNutjaree Jeenduang

Published in: Journal of clinical pharmacy and therapeutics (2018)

SLCO1B1 c.388A>G, c.521T>C and g.89595T>C polymorphisms may not be useful as genetic markers of lipid-lowering response to simvastatin therapy in Thai hypercholesterolaemic patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
stem cells
gene expression
dna methylation
fatty acid
cell therapy
replacement therapy